Research Focus

The link between cancer and organ regeneration is poorly understood. While many cancers develop as a consequence of chronic injury, it’s unclear if a strong regenerative capacity protects against or promotes tumor formation. Too much regeneration could potentially cause cancer by causing organ overgrowth, while too little regeneration could potentially cause cancer by impairing organ function, leading to fibrosis.

Our lab is interested in understanding the relationship between injury, regeneration, and cancer. We are focused on identifying the genes and mechanisms that regulate regenerative capacity in the liver and understanding how these contribute to hepatocellular carcinoma development – the third leading cause of cancer death in the world. Using mouse models developed in our lab that have improved regenerative capacity, we are examining the underlying mechanisms and inherent limitations of regeneration in the liver. Doing so could lead to treatment options that could promote tissue regeneration while preventing cancer.

Research Projects

Reactivation of Embryonic Growth Programs in Liver Cancer

Understanding and Augmenting Liver Regeneration by Dissecting Epigenetic Mechanisms

Understanding the Influence of Regenerative Capacity on Cancer

liver cancer research Reactivation of Embryonic Growth Programs in Liver Cancer

Heterochronic genes encode products whose expression changes throughout time in tissues and temporally regulates developmental changes, organ growth, and regenerative capacity. For example, many heterochronic genes are expressed in fetal, but not adult, tissues such that they promote the rapid growth of fetal tissues and are shut off postnatally. Cancers can reactivate these heterochronic genes in adult tissues to enable neoplastic proliferation. We have uncovered important roles for heterochronic genes by using murine models that allow temporally specific gain or loss of Lin28 and let-7.

We previously showed that adult reactivation of Lin28a promotes regeneration capabilities reminiscent of embryonic tissue (Nguyen et al., 2014). Lin28’s ability to temporally integrate embryonic metabolism, cell proliferation, and tissue growth also contributes to its oncogenic activities. We are currently determining the functions and mechanisms of the oncofetal RNA-binding protein Imp3 (aka Igf2bp3), a well-known downstream target of let-7 and Lin28. Our goal is to define the mechanisms downstream of Imp3 that are therapeutically relevant.

mechanisms of organ regenerationUnderstanding and Augmenting Liver Regeneration by Dissecting Epigenetic Mechanisms

Epigenetic machines reprogram genomic structure, gene expression, and cellular functions during tissue regeneration. It is unknown how this machinery influences regenerative capacity in any tissue system. The liver is the ideal context in which to unravel these longstanding questions. We discovered that Arid1a, a component of the SWI/SNF ATP-dependent chromatin-remodeling complex, plays critical roles in liver injury and regeneration (Sun et al., 2016). Chromatin structure is remodeled during regeneration to alter accessibility for transcription factors that alter cell fate and function such that lost tissues can be replenished. We showed that liver-specific Arid1a knockout mice have enhanced regeneration after multiple forms of surgical, chemical, and genetic injury.

For the first time, these findings connect chromatin-remodeling machinery with organ regeneration and suggest that we have uncovered only the “tip of the iceberg” in terms of understanding the epigenetic mechanisms regulating regeneration. Currently, we are examining how this chromatin-remodeling complex controls gene expression and regeneration on the molecular level.

Understanding the Influence of Regenerative Capacity on Cancer

It is widely assumed that cancer risk increases with regenerative capacity, but we expect the relationship is more complicated. In mammals, chronic organ damage in the skin, lung, intestine, and liver is strongly associated with cancer, but it is possible that the potent regenerative abilities of these organs serve to preserve tissue integrity, reduce inflammation, and resist transformation in the context of recurrent injury. Causative mechanisms have been difficult to study because animals with different regenerative capabilities are often evolutionarily or genetically distant. A general strategy is to develop mice with enhanced or altered organ regeneration in order to understand how modulating regeneration influences carcinogenesis in the liver.

 liver regeneration

This work is inspired by the clinical problem of hepatocellular carcinoma (HCC), a malignancy that arises from a highly regenerative organ that experiences recurrent injury. Although HCC is the third leading cause of cancer death in the world, scientific understanding of HCC is limited – a fact that our inability to predict outcomes, much less treat advanced cases, reflects. A goal for our lab is to understand how influences on regeneration may be employed to control cancer development.

About Dr. Zhu

Hao Zhu, Liver cancer research

Hao Zhu earned his bachelor’s degree in biology from Duke University, followed by an M.D. from Harvard Medical School and MIT. He underwent training in internal medicine at University of California, San Francisco, and medical oncology at the Dana-Farber Cancer Institute. From 2008 to 2012, Dr. Zhu performed postdoctoral research at Boston Children’s Hospital. In 2012, he joined the faculty of the Children’s Medical Center Research Institute at UT Southwestern. He is also an attending physician in the Multidisciplinary Liver Cancer Clinic at Parkland Memorial Hospital.

Dr. Zhu is the recipient of a Burroughs Wellcome Career Award for Medical Scientists (2012), a CPRIT Scholar Award (2012), a Stand Up To Cancer Innovative Research Grant (2016), and Mark Foundation Emerging Leader Award (2021).

Selected Publications

Wang, Z., Zhu, S., Jia, Y., Wang, Y., Kubota, N., Fujiwara, N., Gordillo, R., Lewis, C., Zhu, M., Sharma, T., Li, L., Zeng, Q., Lin, Y.H., Hsieh, M.H., Gopal, P., Wang, T., Hoare, M., Campbell, P., Hoshida, Y., and Zhu, H. (2023). Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease. Cell. 186, 1968-1984. (PubMed)

Lin, Y.H., Wei, Y., Zeng, Q., Wang, Y., Pagani, C.A., Li, L., Zhu, M., Wang, Z., Hsieh, M.H., Corbitt, N., Zhang, Y., Sharma, T., Wang, T., and Zhu, H. (2023). IGFBP2 expressing midlobular hepatocytes preferentially contribute to liver homeostasis and regeneration. Cell Stem Cell. 30, 665-676. (PubMed)

Jia, Y., Li, L., Lin, Y.H., Gopal, P., Shen, S., Zhou, K., Yu, X., Sharma, T., Zhang, Y., Siegwart, D., Ready, J., and Zhu, H. (2022). In vivo CRISPR screening identifies BAZ2 chromatin remodelers as druggable regulators of mammalian liver regeneration. Cell Stem Cell. 3, 372-385. (PubMed)

Wei, Y., Wang, Y.G., Jia, Y., Li, L., Yoon, J., Zhang, S., Wang, Z., Zhang, Y., Zhu, M., Sharma, T., Lin, Y.H., Hsieh, M.H., Albrecht, J.H., Le, P.T., Rosen, C.J., Wang, T., and Zhu, H. (2021). Liver homeostasis is maintained by midlobular zone 2 hepatocytes. Science. 371:eabb1625. (PubMed)

Wang, Z., Chen, K., Jia, Y., Chuang, J.C., Sun, X., Lin, Y.H., Celen, C., Li, L., Huang, F., Liu, X., Castrillon, D.H., Wang, T., and Zhu, H. (2020). Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes Nature Cancer. 1, 909–922. (PubMed)

Lin, Y.H., Zhang, S., Zhu, M., Lu, T., Chen, K., Wen, Z., Wang, S., Xiao, G., Luo, D., Jia, Y., Li, L., MacConmara, M., Hoshida, Y., Singal, A., Yopp, A., Wang, T., and Zhu, H. (2020). Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury. Gastroenterology. 158, 1698-1712. (PubMed

Zhu, M., Lu, T., Jia, Y., Luo, X., Gopal, P., Li, L., Odewole, M., Renteria, V., Singal, A.G., Jang, Y., Ge, K., Wang, S.C., Sorouri, M., Parekh, J.R., MacConmara, M.P., Yopp, A.C., Wang, T., and Zhu, H. (2019). Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease. Cell. 177, 608-621. (PubMed)

Zhang, S., Zhou, K., Luo, X., Li, L., Tu, H.C., Sehgal, A., Nguyen, L.H., Zhang, Yu., Gopal, P., Tarlow, B., Siegwart, D.J., and Zhu, H. (2018). The polyploid state plays a tumor-suppressive role in the liver.  Developmental Cell.  44, 447-459. (PubMed)

Zhang, S., Nguyen, L.H., Zhou, K., Tu, H.C., Sehgal, A., Nassour, I., Li, L., Gopal, P., Goodman, J.,  Singal, A.G., Yopp, A., Zhang, Y., Siegwart, D.J., and Zhu, H. (2017). Knockdown of Anillin Actin Binding Protein Blocks Cytokinesis in Hepatocytes and Reduces Liver Tumor Development in Mice Without Affecting Regeneration. Gastroenterology. 154, 1421-1434. (PubMed)

Sun, X.*, Wang, S.C.*, Luo, X., Jia, Y., Li, L., Gopal, P., Zhu, M., Nassour, I., Chuang, J.C., Maples, T., Celen, C., Nguyen, L.H., Wu, L., Fu, S., Li, W., Hui, L., Tian, F., Ji, Y., Zhang, S., Sorouri, M., Hwang, T.H., Letzig, L., James, L., Yopp, A., Singal, A., and Zhu, H.  (2017). Arid1a has context-dependent oncogenic and tumor suppressor functions in liver cancer. Cancer Cell. 32, 574-589. (PubMed) *Equal contributors.

Sun, X., Chuang, J.C., Kanchwala, M., Wu, L., Celen, C., Li, L., Liang, H., Zhang, S., Maples, T., Nguyen, L.H., Wang, S.C., Signer, R.A., Sorouri, M., Nassour, I., Liu, X., Xu, J., Wu, M., Zhao, Y., Kuo, Y.C., Wang, Z., Xing, C., and Zhu, H. (2016). Suppression of the SWI/SNF Component Arid1a Promotes Mammalian Regeneration. Cell Stem Cell. 18, 456–466. (PubMed)

Wu, L.*, Nguyen, L.H.*, Zhou, K., Soysa, T.Y., Li, L., Miller, J.B., Tian, J., Locker, J., Zhang, S., Shinoda, G., Seligson, M.T., Zeitels, L.R., Acharya, A., Wang, S.C., Mendell, J.T., He, X., Nishino, J., Morrison, S.J., Siegwart, D.J., Daley, G.Q., Shyh-Chang, N., and Zhu, H.  (2015). Precise Let-7 expression levels balance organ regeneration against tumor suppression. eLife. 4:e09431. (PubMed) *Equal contributors

Nguyen, L.H.*, Robinton, D.A.*, Seligson, M.T.*, Wu, L., Li, L., Rakheja, D., Comerford, S.A., Ramezani, S., Sun, X., Parikh, M.S., Yang, E.H., Powers, J.T., Shinoda, G., Shah, S.P., Hammer, R.E., Daley, G.Q.,** and Zhu, H.**. (2014). Lin28b is sufficient to drive liver cancer and necessary for its maintenance in murine models. Cancer Cell. 26, 248–261. (PubMed) *Equal contributors. **Co-corresponding authors.


Lab News


Lab Members

Amaey Bellary, B.S.

Research Technician

Natasha Corbitt, M.D., Ph.D.

Assistant Professor, Pediatric Surgery

Ivy Fang, B.S.

Ph.D. Student

Sean Hsieh, M.S.

Ph.D. Student

Lin Li, M.S.

Lab Manager/Senior Research Scientist

Zhijie Li, Ph.D.

Postdoctoral Fellow

Roger Liang, B.S.

M.D./Ph.D Student

Yi Zou Lim, B.S.

Research Assistant

Gianna Maggiore, B.S.

M.D./Ph.D. Student

Stephen Moore, B.S.

Ph.D. Student

Kevin Mutore, M.D.

TARDIS Research Fellow

Jingjing Wang, M.S.

Research Assistant

Qiyu Zeng, Ph.D

Postdoctoral Fellow

Min Zhu, Ph.D.

Research Scientist

Andrew Chung, Ph.D.

MSTP Student, UT Southwestern Medical School

M.D./Ph.D Student (2016-2021)

Cemre Celen, Ph.D.

Scientist, Genentech

Grad Student (2015-2020)

Jen-Chien Chuang, Ph.D.

Associate Director, Takeda

Assistant Instructor (2014-2016)

Yuemeng Jia, B.S.

Postdoctoral Fellow, Harvard

Ph.D. Student (2017-2022)

John Karalis, M.D.

General Surgery Resident, UT Southwestern

General Surgery Fellow (2020-2022)

Yu-Hsuan Lin, Ph.D.

Scientist I, Nkarta

Ph.D. Student (2018-2022)

Ningning Liu, Ph.D.

Assistant Professor, Institute of Microbiology of the Chinese Academy of Sciences

Assistant Instructor (2021-2022)

Tianshi Lu, Ph.D.

Scientist, Genentech

Graduate Student (2017-2021)

Xin Luo, Ph.D.

Scientist, Genome Analysis Unit (Computational Biology), Amgen

Data Scientist (2016-2018)

Austin Moore, Ph.D.

Pediatrics Resident, Boston Children’s Hospital

M.D./Ph.D Student (2016-2021)

Ibrahim Nassour, M.D.

Assistant Professor, Department of Surgery, University of Florida

Clinical Fellow, Surgery (2015-2017)

Liem Nguyen, M.D., Ph.D.

Internal Medicine Resident, University of Washington

Ph.D. Student (2013- 2017)

Shunli Shen, M.D., Ph.D.

Associate Professor, First Affiliated Hospital, Sun Yat-sen University

Visiting Scholar (2018)

XuXu Sun, Ph.D.

Assistant Professor, Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University

Postdoctoral Fellow (2013-2019)

Sam Wang, M.D.

Associate Professor, Department of Surgery

Assistant Professor, Department of Surgery (2014-2022)

Zixi Wang, M.D.

Assistant Professor, Shenzhen, China

Postdoctoral Fellow (2016-2023)

Yonglong Wei, Ph.D.

Assistant Professor, Center for Life Science, Yunnan University

Postdoctoral Fellow (2016-2022)

Linwei Wu, Ph.D.

Associate Professor, First Affiliated Hospital, Sun Yat-sen University

Visiting Scholar (2013–2015)

Shu Xiao, Ph.D.

Senior Research Associate, Department of Surgery

Senior Research Associate (2018-2022)

Shuyuan Zhang

Postdoctoral Fellow, Stanford University

Ph.D. Student (2013-2018)

6000 Harry Hines Blvd.
Dallas, TX 75235